D-0050-2027 Class II Ongoing

Recalled by Shenzhen Techdow Pharmaceutical Co., Ltd. — Shenzhen

FDA drug recall D-0050-2027 was initiated by Shenzhen Techdow Pharmaceutical Co., Ltd. on Oct 1, 2026 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is ongoing. Affected quantity: 251,000 1 mL multidose vials.

Recall details

Product Type
Drugs
Report Date
Oct 28, 2026
Initiation Date
Oct 1, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
251,000 1 mL multidose vials

Product description

Heparin Sodium Injection, USP, 5,000 USP Units/mL, 1mL Multi dose vial x 25 vials per carton, Distributed by: Hepalink USA Inc., Langhome, PA 19047-1885. Carton NDC: NDC 81952-111-06, Vial NDC: 81942-111-01

Reason for recall

Lack of Assurance of Sterility

Distribution pattern

Nationwide in the USA.

Code information

Lot# CU03232A, Exp 1/31/2028

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0050-2027
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0050-2027. Report a data issue: hello@regdatalab.com.